Strata Critical Medical, Inc.: Form 10-K for the period ended Dec 31, 2024
Filed with the SEC on Mar 13, 2025 and accepted by EDGAR at Mar 13, 2025, 18:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $248.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $189.8m | us-gaap:CostOfRevenue |
| Operating income | 12 months2024-01-01 to 2024-12-31 | −$33.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-01-01 to 2024-12-31 | −$255.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | −$27.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 77,499,423 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | −$2.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $30.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2024-01-01 to 2024-12-31 | $244.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-12-31 | $18.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $160.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $256.7m | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $22.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $34.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-12-31 | $221.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001779128-25-000010. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.